아위로부터 분리된 세스키테르펜 화합물을 포함하는 항암제 조성물
    3.
    发明公开
    아위로부터 분리된 세스키테르펜 화합물을 포함하는 항암제 조성물 失效
    含有由ASAFOETIDA分离的SESQUITERPENE化合物的反应物组合物

    公开(公告)号:KR1020020029210A

    公开(公告)日:2002-04-18

    申请号:KR1020000060039

    申请日:2000-10-12

    Abstract: PURPOSE: An anticancer composition containing sesquiterpene compounds separated from asafoetida exhibiting an excellent cell proliferation inhibiting effect against a human cancer cell line is provided which can be used as a preventive and therapeutic agent against various malignant tumors such as lung cancer, ovarian cancer, melanoma, central nervous tumor colon cancer or the like. CONSTITUTION: This anticancer composition contains sesquiterpene compounds separated from asafoetida, namely one selected from the group consisting of galvanic acid, karatavicinol, umbelliprenin, farnesiferol B, farnesiferol C and mixtures thereof separated from asafoetida as an effective agent and a pharmaceutically acceptable carrier.

    Abstract translation: 目的:提供一种抗癌组合物,其含有对于表达对人癌细胞系具有优异的细胞增殖抑制作用的从三萜烯分离的倍半萜化合物,其可用作针对各种恶性肿瘤如肺癌,卵巢癌,黑素瘤, 中枢神经肿瘤结肠癌等。 构成:该抗癌剂组合物含有从沙蒿中分离出的倍半萜化合物,即选自起始酸,卡拉他宁,伞形螺蛋白,法尼塞醇B,法呢松酚C及其作为有效药剂分离的混合物的一种和药学上可接受的载体。

    케텐 디티오 아세틸 α-아닐리드 유도체
    8.
    发明授权
    케텐 디티오 아세틸 α-아닐리드 유도체 失效
    KETENE DITHIO ACETALœ-苯胺衍生物

    公开(公告)号:KR1019940009934B1

    公开(公告)日:1994-10-19

    申请号:KR1019910005390

    申请日:1991-04-03

    Abstract: New sterilized compound having a wide sterilizing effect and power is prepd. by: (A) synthesis of β-keto anilide of formula (II) from aniline; (B) synthesis of ketene dithio acetal α-anilide of formula (I) by reacting (II) and alkyl halide, dialkyl sulfate, alkyl alkyl or allyl sulfonate of formula (III) in the presence of CS2. In the formulas, R1, R2, R3, R4 are same or different, respectively hydrogen, aryl and aryl oxy and alkyl, alkenyl, alkoxy, thio alkyl, haloalkyl, nitro, cyano, aryl sulfonyl group; R5 is alkyl, hydrogen or halogen substituted aryl, group; R6 is alkyl or alkyl haloalkyl group.

    Abstract translation: 具有广泛消毒效果和功效的新型灭菌化合物制备。 通过:(A)从苯胺合成式(II)的β-酮苯胺; (B)在CS2存在下,使式(I)的(II)和卤代烷基,硫酸二烷基酯,式(III)的烷基或烯丙基磺酸烷基酯反应合成式(I)的烯酮二硫代缩醛α-苯胺。 在式中,R 1,R 2,R 3,R 4分别相同或不同,分别为氢,芳基和芳氧基和烷基,烯基,烷氧基,硫代烷基,卤代烷基,硝基,氰基,芳基磺酰基; R5是烷基,氢或卤素取代的芳基,基团; R6是烷基或烷基卤代烷基。

Patent Agency Ranking